Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.72 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | DHODH | Q02127 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.35 |
| ▸ | PTGES | O14684 | 2/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | DLAT | P10515 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13629034 | 0.86 | ALOX5 (0.56) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL29420850 | 0.85 | ALOX5 (0.80) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL29420849 | 0.85 | ALOX5 (0.80) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL17584889 | 0.85 | ALOX5 (0.80) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL9773779 | 0.84 | ALOX5 (1.00) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL6125218 | 0.84 | ALOX5 (1.00) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL144835 | 0.84 | ALOX5 (1.00) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL6125220 | 0.84 | ALOX5 (1.00) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| Ammonia Solution, Strong SCHEMBL21582009 | 0.82 | ALOX5 (0.98) | KDM4EMEN1KMT2AALOX5AKR1B10 | |
| SCHEMBL5967762 | 0.82 | ALOX5 (0.80) | KDM4EMEN1KMT2AALOX5AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090286884-A1 | Hops Beta-Acid Anti-Diabetic Composition | Haas, John I. (US) | 2009-11-19 | — | — | US | disclosed |
| US-20090286884-A1 | Hops Beta-Acid Anti-Diabetic Composition | Haas, John I. (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286884-A1 | Hops Beta-Acid Anti-Diabetic Composition | GYS2, HBB, HBG2 | KDM4E 4830/4885MEN1 2631/4885KMT2A 4638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.